Respiratory Infections News

An FDA advisory committee on Thursday voted in favor of approving the long-acting monoclonal antibody nirsevimab to protect neonates and infants from respiratory syncytial virus.

A review of nearly 250,000 doses of messenger RNA COVID-19 vaccine administered to young children identified no serious side effects from the shots, according to results published in Pediatrics.

As an outpatient treatment for COVID-19, the antivirals Paxlovid and Lagevrio were both associated with reduced mortality rates, but only Paxlovid was associated with a reduction in hospitalization, data show.

Transplant medicine and the field of transplant infectious diseases have faced numerous disruptions and challenges during the COVID-19 pandemic, according to experts.

Among more than 72,000 blood donors in the United States aged 16 years or older, 96% had antibodies against the virus that causes COVID-19 by late last year, according to a new analysis.

President Joe Biden is set to announce former North Carolina secretary of health Mandy K. Cohen, MD, MPH, as the next director of the CDC, according to multiple reports.

The FDA this week approved Pfizer’s respiratory syncytial virus vaccine for adults aged 60 years or older — the second RSV vaccine approved for this population in the last month.

Researchers found that patients hospitalized withCOVID-19 received antibiotics for potential secondary bacterial infections without clinical indications suggesting they could benefit from the treatment.

Using artificial intelligence for patient triaging has the potential to streamline health care services while also tackling issues like antibiotic resistance, according to researchers.

Global data indicate that some common influenza symptoms increase with age as others decrease, researchers found.